Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry|February 14, 2013
Olive secoiridoids and semisynthetic bioisostere analogues for the control of metastatic breast cancerBelnaser A Busnena, Ahmed I Foudah, Tina Melancon, et al.
International Journal of Pharmaceutics|August 9, 2019
Novel olive oil phenolic (-)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activitiesMohammed H Qusa, Abu Bakar Siddique, Sami Nazzal, et al.
The Journal of Organic Chemistry|September 20, 1996
Kahalalides: Bioactive Peptides from a Marine Mollusk Elysia rufescens and Its Algal Diet Bryopsis sp.(1)Mark T. Hamann, Clifton S. Otto, Paul J. Scheuer, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|July 23, 2016
Discovery and preliminary structure-activity relationship of the marine natural product manzamines as herpes simplex virus type-1 inhibitorsJayavardhana R Palem, Mudit Mudit, Shao-Chung V Hsia, et al.
Nutrients|February 11, 2023
<i>S</i>-(-)-Oleocanthal Ex Vivo Modulatory Effects on Gut MicrobiotaMohammed H Qusa, Khaldoun S Abdelwahed, Ronald A Hill, et al.
Nutrients|June 2, 2021
Comparative Gene Signature of (-)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target InsightsMohammed H Qusa, Khaldoun S Abdelwahed, Abu Bakar Siddique, et al.
Phytotherapy Research : PTR|August 8, 2015
Olive Oil-derived Oleocanthal as Potent Inhibitor of Mammalian Target of Rapamycin: Biological Evaluation and Molecular Modeling StudiesMohammad A Khanfar, Sanaa K Bardaweel, Mohamed R Akl, et al.
European Journal of Medicinal Chemistry|February 4, 2014
Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitorsAhmed I Foudah, Asmaa A Sallam, Mohamed R Akl, et al.
Bioorganic & Medicinal Chemistry|September 30, 2016
(1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignanciesHassan Y Ebrahim, Mohamed M Mohyeldin, Mohammad M Hailat, et al.
Bioorganic & Medicinal Chemistry|December 22, 2009
Design and preliminary structure-activity relationship of redox-silent semisynthetic tocotrienol analogues as inhibitors for breast cancer proliferation and invasionAhmed Y Elnagar, Vikram B Wali, Paul W Sylvester, et al.
Pageof 13